InMedica - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 8,330,092 | 12,632,609 | 17,955,910 | 35,888,311 | 37,261,700 | 85,740,287 | 103,979,304 | 147,056,401 |
| Profit before tax | 141,690 | 821,521 | 1,493,730 | 6,218,368 | 47,527 | -2,928,831 | 1,950,143 | 1,411,445 |
| Net profit | 141,690 | - | - | - | -36,227 | -233,531 | 3,257,958 | -2,826,225 |
| Equity | 1,703,405 | 2,347,359 | 3,903,723 | 9,529,166 | 30,859,333 | 33,640,981 | 36,898,940 | 52,005,017 |
| Liabilities | 2,924,264 | - | - | - | 66,599,427 | 94,811,129 | 103,169,834 | 131,917,636 |
| Non-current assets | 3,762,959 | 10,402,257 | 13,782,780 | 22,417,562 | 94,788,476 | 119,423,556 | 132,626,429 | 166,856,276 |
| Current assets | 853,632 | 3,558,964 | 6,505,344 | 12,283,228 | 2,670,284 | 9,028,554 | 7,442,345 | 17,066,377 |
| Total assets | 4,616,591 | 13,961,221 | 20,288,124 | 34,700,790 | 97,458,760 | 128,452,110 | 140,068,774 | 183,922,653 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 10,953,316 | 14,479,456 | 19,774,526 |
| Social insurance contributions | - | - | - | - | - | 11,341,510 | 14,561,399 | 20,024,560 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +34.3% | +51.7% | +42.1% | +99.9% | +3.8% | +130.1% | +21.3% | +41.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3.1% | - | - | - | 0.0% | -0.2% | 2.3% | -1.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 8.3% | - | - | - | -0.1% | -0.7% | 8.8% | -5.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.7% | - | - | - | -0.1% | -0.3% | 3.1% | -1.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.7% | 6.5% | 8.3% | 17.3% | 0.1% | -3.4% | 1.9% | 1.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.7 | - | - | - | 2.2 | 2.8 | 2.8 | 2.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 19,775 | 24,609 | 26,239 | 39,485 | 33,841 | 39,496 | 41,026 | 46,596 |
Sales revenue
Consolidated InMedica finance
|
EUR
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 86,518,731 | 124,998,559 | 152,400,748 |
| Profit before tax | 7,742,060 | 6,200,764 | 12,995,183 |
| Net profit | 7,049,357 | 8,217,741 | 13,524,830 |
| Equity | 41,380,748 | 49,603,695 | 63,128,526 |
| Liabilities | 74,642,108 | 89,082,421 | 90,722,121 |
| Non-current assets | 104,208,296 | 124,084,759 | 137,439,490 |
| Current assets | 11,814,560 | 14,601,357 | 16,411,157 |
| Total assets | 116,022,856 | 138,686,116 | 153,850,647 |
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
InMedica - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-03-18 | 2024-03-18 | 7863.41 |
| 2024-02-21 | 2024-03-12 | 8515.70 |
| 2024-02-19 | 2024-02-20 | 8703.92 |
| 2023-05-16 | 2023-05-16 | 945424.51 |
| 2023-05-11 | 2023-05-15 | 28940.48 |
| 2023-05-02 | 2023-05-10 | 28963.16 |
| 2023-04-26 | 2023-04-28 | 28963.16 |
| 2023-03-16 | 2023-03-19 | 24213.18 |
InMedica - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.